Re-imagining Oral Semaglutide in Routine Clinical Practice: Indian Expert Panel Recommendations
Background: The rising prevalence of type 2 diabetes mellitus (T2DM) in India, driven by obesity and lifestyle factors, necessitates innovative treatments like oral Semaglutide, a GLP-1 receptor agonist (GLP-1RA). Its oral formulation enhances patient adherence by overcoming barriers associated with...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wolters Kluwer Medknow Publications
2025-07-01
|
| Schriftenreihe: | International Journal of Diabetes and Technology |
| Schlagworte: | |
| Online-Zugang: | https://journals.lww.com/10.4103/ijdt.ijdt_18_25 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|